Cellyan Biotechnology Co., Ltd Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity
Cellyan Biotechnology Co., Ltd (HKPD) reported Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity of $153.74 thousand for the 6-month period ending 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity · last filed 2026-03-18
| Period end | Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity 6 month | Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity 12 month |
|---|---|---|
| 2025-09-30 | $153.74K 6-K · filed 2026-03-18 | |
| 2025-03-31 | -$27.06K 20-F · filed 2025-08-14 | |
| 2024-09-30 | $828.56K 6-K · filed 2026-03-18 | |
| 2024-03-31 | $1.33M 20-F · filed 2025-08-14 | |
| 2023-03-31 | $998.20K 20-F · filed 2025-08-14 |